Finch Therapeutics Group, Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Volatile ride for Finch Therapeutics Group, Inc. stock price on Friday moving between $2.10 and $2.43
(Updated on Apr 26, 2024)
The Finch Therapeutics Group, Inc. stock price gained 3.57% on the last trading day (Friday, 26th Apr 2024), rising from $2.24 to $2.32. During the last trading day the stock fluctuated 15.99% from a day low at $2.10 to a day high of $2.43. The price has been going up and down for this period, and there has been a 14.29% gain for the last 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 37 thousand shares were bought and sold for approximately $86.83 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.31% during the next 3 months and, with a 90% probability hold a price between $1.82 and $2.99 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
FNCH Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 3.57%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Finch Therapeutics Group, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.37 and $2.52. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Finch Therapeutics Group, Inc. stock
Finch Therapeutics Group, Inc. finds support from accumulated volume at $2.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.335 between high and low, or 15.99%. For the last week the stock has had daily average volatility of 17.26%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (FNCH) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Finch Therapeutics Group, Inc. to open at $2.28, and during the day (based on 14 day Average True Range), to move between $1.93 and $2.71, which gives a possible trading interval of +/-$0.392 (+/-16.89%) up or down from last closing price. If Finch Therapeutics Group, Inc. takes out the full calculated possible swing range there will be an estimated 33.78% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.31 (0.43%) than the resistance at $2.52 (8.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Finch Therapeutics Group, Inc. stock A Buy?
Finch Therapeutics Group, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.917 Sell Candidate Upgraded
Predicted Opening Price for Finch Therapeutics Group, Inc. of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $2.28 ( 1.65%) | $2.32 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for FNCH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.62 | 12.79 % | |
| R2 | 2.49 | 7.27 % | ||
| R1 | 2.41 | 3.86 % | ||
| Current price: | 2.32 | |||
| Support | S1 | 2.15 | -7.17 % | |
| S2 | 2.07 | -10.58 % | ||
| S3 | 1.95 | -16.09 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.79 | 20.21 % | |
| R2 | 2.69 | 15.95 % | ||
| R1 | 2.52 | 8.62 % | ||
| Current price | 2.32 | |||
| Support | S1 | 2.31 | -0.431% | |
| S2 | 2.30 | -0.86% | ||
| S3 | 2.24 | -3.45% |
FAQ
Click here for our free guide on how to buy Finch Therapeutics Group, Inc. Stock.
